Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Advent

- PMLiVE

Sanofi’s Sarclisa granted EC approval to treat newly diagnosed multiple myeloma

Approximately 46,000 cases of the disease are expected to be diagnosed in Europe in 2025

- PMLiVE

Sanofi announces positive phase 3 results for subcutaneous Sarclisa in multiple myeloma

Approximately 32,000 people are diagnosed with the haematological malignancy in the US every year

- PMLiVE

Sanofi and Alloy Therapeutics enter central nervous system deal worth over $427m

The agreement allows Sanofi to use Alloy’s antisense platform for a central nervous system target

- PMLiVE

Sanofi and SK bioscience expand pneumococcal vaccine collaboration

The partners’ 21-valent paediatric vaccine entered late-stage clinical development last month

- PMLiVE

Sanofi’s BTK inhibitor tolebrutinib granted FDA breakthrough designation for MS

The neurological disorder affects approximately 2.9 million people globally

- PMLiVE

Sanofi receives FDA fast track designation for COVID-19/flu combination vaccines

The combined vaccine approach could simplify immunisation practices and lead to higher uptake

- PMLiVE

Sanofi’s rilzabrutinib shows promise in phase 3 immune thrombocytopenia study

Approximately 9.5 per 100,000 people in the US are affected by the rare autoimmune disorder

- PMLiVE

Sanofi unveils plans to build €1bn insulin production base in China

The site will focus on serving the insulin medication needs of local diabetic patients

- PMLiVE

Sanofi opens €558m modular concept manufacturing facility in Singapore

The facility is designed to enable rapid changes in production capacities across medicines

- PMLiVE

European Medicines Group appoints Rippon Ubhi as chair

Ubhi will maintain her role as country lead for Sanofi UK and Ireland

- PMLiVE

Sanofi/Regeneron’s Dupixent approved by EC for younger eosinophilic oesophagitis patients

Dupixent is now the first drug in the EU indicated for use in this patient population

- PMLiVE

Unlocking potential: key life sciences priorities for the Autumn Budget

By Ahmed Moussa

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links